» Articles » PMID: 26989577

The Burn Wound Microenvironment

Overview
Date 2016 Mar 19
PMID 26989577
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

While the survival rate of the severely burned patient has improved significantly, relatively little progress has been made in treatment or prevention of burn-induced long-term sequelae, such as contraction and fibrosis. Our knowledge of the molecular pathways involved in burn wounds has increased dramatically, and technological advances now allow large-scale genomic studies, providing a global view of wound healing processes. Translating findings from a large number of and preclinical animal studies into clinical practice represents a gap in our understanding, and the failures of a number of clinical trials suggest that targeting single pathways or cytokines may not be the best approach. Significant opportunities for improvement exist. Study of the underlying molecular influences of burn wound healing progression will undoubtedly continue as an active research focus. Increasing our knowledge of these processes will identify additional therapeutic targets, supporting informed clinical studies that translate into clinical relevance and practice.

Citing Articles

Efficacy of neutral electrolyzed water vs. common topical antiseptics in the healing of full‑thickness burn: Preclinical trial in a mouse model.

Delgado-Enciso I, Aurelien-Cabezas N, Meza-Robles C, Walle-Guillen M, Hernandez-Fuentes G, Cabrera-Licona A Biomed Rep. 2024; 21(6):189.

PMID: 39479362 PMC: 11522847. DOI: 10.3892/br.2024.1877.


and studies of the effects of oil extracted from L. seeds on healing of burned skin wounds in rats.

Bouarfa M, Chebaibi M, Amrati F, Souirti Z, Saghrouchni H, Atki Y Front Chem. 2024; 12:1381527.

PMID: 38919274 PMC: 11197104. DOI: 10.3389/fchem.2024.1381527.


The Combination of Stromal Vascular Fraction Cells and Platelet-Rich Plasma Increases Fibroblast Growth Factor 2 and Insulin-Like Growth Factor 1 in Full-Thickness Burns in Animal Model.

Josh F, Soekamto T, Windura C, Lumalessil D Ann Burns Fire Disasters. 2024; 37(1):35-44.

PMID: 38680831 PMC: 11041884.


The Combination of Stromal Vascular Fraction Cells and Platelet-Rich Plasma Mediates the Inflammatory Process in Deep Dermal Burn Injury.

Pakan A, Josh F, Soekamto T, Hendarto J Ann Burns Fire Disasters. 2024; 36(4):320-330.

PMID: 38680233 PMC: 11041994.


Adipose-derived stem cells enriched with therapeutic mRNA TGF-β3 and IL-10 synergistically promote scar-less wound healing in preclinical models.

Wang W, Chen L, Zhang Y, Wang H, Dong D, Zhu J Bioeng Transl Med. 2024; 9(2):e10620.

PMID: 38435824 PMC: 10905533. DOI: 10.1002/btm2.10620.


References
1.
Wainwright D . Use of an acellular allograft dermal matrix (AlloDerm) in the management of full-thickness burns. Burns. 1995; 21(4):243-8. DOI: 10.1016/0305-4179(95)93866-i. View

2.
Rook J, Hasan W, McCarson K . Temporal effects of topical morphine application on cutaneous wound healing. Anesthesiology. 2008; 109(1):130-6. PMC: 2598738. DOI: 10.1097/ALN.0b013e31817b5ac3. View

3.
Bang R, Sharma P, Sanyal S, Al Najjadah I . Septicaemia after burn injury: a comparative study. Burns. 2002; 28(8):746-51. DOI: 10.1016/s0305-4179(02)00183-3. View

4.
Hicks C, Khorasanee J, Gamelli R . Genomics of burn injury and its promise in clinical practice. J Burn Care Res. 2008; 29(6):877-86. DOI: 10.1097/BCR.0b013e31818cb070. View

5.
Wolfe J, Wu A, OConnor N, Saporoschetz I, Mannick J . Anergy, immunosuppressive serum, and impaired lymphocyte blastogenesis in burn patients. Arch Surg. 1982; 117(10):1266-71. DOI: 10.1001/archsurg.1982.01380340002002. View